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The exopolysaccharide capsule of Streptococcus pneumoniae
is an important virulence factor, but the mechanisms that regu-
late capsule thickness are not fully understood. Here, we inves-
tigated the effects of various exogenously supplied carbohy-
drates on capsule production and gene expression in several
pneumococcal serotypes. Microscopy analyses indicated a near
absence of the capsular polysaccharide (CPS) when S. pneu-
moniae was grown on fructose. Moreover, serotype 7F pneumo-
cocci produced much less CPS than strains of other serotypes
(6B, 6C, 9V, 15, and 23F) when grown on glucose or sucrose.
RNA-sequencing revealed carbon source-dependent regulation
of distinct genes of WT strains and capsule-switch mutants of
serotypes 6B and 7F, but could not explain the mechanism of
capsule thickness regulation. In contrast, 31P NMR of whole-cell
extract from capsule-knockout strains (cps) clearly revealed
the accumulation or absence of capsule precursor metabolites
when cells were grown on glucose or fructose, respectively. This
finding suggests that fructose uptake mainly results in intracel-
lular fructose 1-phosphate, which is not converted to CPS pre-
cursors. In addition, serotype 7F strains accumulated more pre-
cursors than did 6B strains, indicating less efficient conversion
of precursor metabolites into the CPS in 7F, in line with its thin-
ner capsule. Finally, isotopologue sucrose labeling and NMR
analyses revealed that the uptake of the labeled fructose subunit
into the capsule is <10% that of glucose. Our findings on the
effects of carbon sources on CPS production in different
S. pneumoniae serotypes may contribute to a better understand-
ing of pneumococcal diseases and could inform future therapeu-
tic approaches.
Streptococcus pneumoniae (the pneumococcus) is a patho-
biont mainly colonizing the nasal passages but capable of caus-
ing invasive disease (1). Thus it is exposed to a variety of nutri-
ent profiles in its environment, such as a glucose-dominated
environment in the blood or a galactose (and GlcNAc)-
dominated environment in the respiratory mucus of the naso-
pharynx (2). Recent studies have investigated the host glycan
sugar-specific pathways in S. pneumoniae (3, 4). This has pro-
vided an accurate map of the biochemical pathways for the
pneumococcal galactose, mannose, and GlcNAc catabolism. It
also has been shown that the transcriptional response to glu-
cose is strong and that in the central carbon metabolism, glu-
cose exerts mostly negative regulation (5). Recently, the growth
and metabolism of S. pneumoniae has been studied by in vivo
NMR techniques, which has paved the way to a better under-
standing of central metabolism regulation (6) (Fig. 1). The cen-
tral carbon metabolism of S. pneumoniae has also been studied
by isotopologue profiling, which allowed investigation of the
biosynthesis of amino acids (7).
It is believed that the nutritional environment may not only
influence the metabolism but is also relevant for the expression
of one of the main pneumococcal virulence factors, its polysac-
charide capsule. It has been shown that changes in availability
of oxygen accentuate differences in capsular polysaccharide
expression (8). In addition, we have studied the capsule type
in pneumococcal strains grown in nutrient-restricted Lacks
medium (MLM) and in rich undefined brain heart infusion
broth supplemented with 5% fetal calf serum (BHI  FCS) and
have shown that certain pneumococcal strains produce less
exopolysaccharide if grown in nutrient-restricted conditions
(9). Different carbon sources present in the environment may
also affect capsule expression differently. Using chemically
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defined media (CDM),2 it has been shown that S. pneumoniae
grown on fructose produce less capsule polysaccharide than
those grown on glucose as the sole carbon source (10). The
effect of other carbon sources on the capsule is less clear,
although it has been speculated that in medium containing
galactose, the amount of capsule produced is higher than com-
pared with glucose (11).
Carbohydrates enter the pneumococcal cell via different
transporters, and many of them have been investigated (12).
There is complexity to the pneumococcal sugar uptake, as
many transporters accept multiple substrates, and many sugars
are transported by more than one system (12). The principal
glucose transporter in S. pneumoniae is the mannose type PTS
manLMN. It has been shown by mutant analyses that the dele-
tion of this PTS was the only one to affect the utilization of
glucose (12) (Fig. 1). However, other routes of glucose impor-
tation are hypothesized including uptake by ABC transporters
(11). As for fructose, the relevance of the fruRBA operon as a
phosphoenolpyruvate-phosphotransferase system (PTS) has
been described for S. pneumoniae but also for Group A Strep-
tococci (12, 13). However, again, the PTS manLMN or non-PTS
as illustrated for Escherichia coli could hypothetically import
fructose (12, 14). On the other hand, sucrose (disaccharide glu-
cose-fructose) is probably taken up via a different PTS trans-
porter (ScrT) and afterward processed to glucose 6-phosphate
and fructose (4).
In this study, we elucidate the influence of three different
saccharides (glucose, fructose, and sucrose) on the capsule bio-
synthesis in various strains of S. pneumoniae, both commensal
and invasive. For investigating the influence of the different
carbon sources on gene expression, RNA-Sequencing (Seq) was
conducted and phosphorylated metabolites, which are impor-
tant for capsule composition were quantified by 31P NMR. In
addition, isotopologue profiling was performed to study 13C-
labeled glucose and sucrose incorporation into the pneumo-
coccal capsule and to better understand the mechanism behind
the capsule expression.
2 The abbreviations used are: CDM, chemically defined medium; CPS, capsu-
lar polysaccharide; FBP, fructose 1,6-bisphosphate; FITC, fluorescein iso-
thiocyanate; FOS, fructooligosaccharides; GlcA, glucuronic acid; Glc-N,
glucosamine; MurNAc-p5, N-acetylmuramate-pentapeptide; PRPP, phos-
phoribosyl pyrophosphate; PTS, phosphotransferase transport system;
TEM, transmission electron microscopy; UDP, uridine diphosphate; PCA,
principal component analysis; EPS, exopolysaccharide; TPM, transcripts
per million; PPA, phosphonoacetic acid; nt, nucleotide.
Figure 1. Schematic illustration of metabolic pathways in S. pneumoniae. Adapted from Refs. 3, 11, 14, and 53. I: fruA fructose uptake phosphotransferase
transporter (red); II: manLMN monosaccharide uptake phosphotransferase transporter (red); III: membrane-spanning protein able to take up free fructose, PtsG
analog (red); 1,3-DPG, 1,3-diphosphoglycerate; 3-PG, 3-phosphoglycerate; 6-PGL, 6-phosphogluconolactonase; DHAP, dihydroxyacetone phosphate; fba, fruc-
tose-bisphosphate aldolase; fki, fructokinase; Frc-1,6bP, fructose 1,6-bisphosphate; Frc-1P, fructose 1-phosphate; Frc-6P, fructose 6-phosphate; G6PDH, glucose
6-phosphate dehydrogenase; gale, UDP-glucose 4-epimerase; galU, glucose 1-phosphate uridyltransferase; GAP, glyceraldehyde 3-phosphate; gapA, glycer-
aldehyde 3-phosphate dehydrogenase; gapN, glyceraldehyde 3-phosphate dehydrogenase (NADP); gki, glucokinase (orange); Glc-1,5lac-6P, glucono-1,5-
lactone 6-phosphate; Glc-1P, glucose 1-phosphate; Glc-6P, glucose 6-phosphate; GlcN-1P, glucosamine 1-phosphate; GlcN-6P, glucosamine 6-phosphate;
GlcNAc-1P, GlcNAc 1-phosphate; GlcNAc-6P, GlcNAc 6-phosphate; glmM, phosphoglucosamine mutase; glmS, glutamine-fructose 6-phosphate aminotrans-
ferase; glmU, bifunctional protein (acetyltransferase, uridyltransferase); gnd, 6-phosphogluconate dehydrogenase; manLMN, monosaccharide uptake phos-
photransferase (orange); murA, UDP-GlcNAc enolpyruvyl transferase; murB, UDP-N-acetylenolpyruvoylglucosamine reductase; murC-F, peptide ligases; nagA,
-N-acetylgalactosaminidase; nagB, glucosamine 6-phosphate deaminase; pfkA, ATP-dependent 6-phosphofructokinase; pfkB, 1-phosphofructokinase; pgi,
glucose 6-phosphate isomerase; pgk, phosphoglycerate kinase; pgm, phosphoglucomutase; rpiA, ribose-5-phosphate isomerase; ScrT, sucrose phosphotrans-
ferase transporter (green); tkt1, transketolase; tpiA, triose-phosphate isomerase; UDP-Gal, uridine diphosphate galactose; UDP-Glc, uridine diphosphate glu-
cose; UDP-GlcNAc, uridine diphosphate GlcNAc; UDP-MurNAc, uridine diphosphate N-acetylmuramate; UDP-MurNAc-p5, uridine diphosphate N-acetylmura-
mate pentapeptide. Hypothetical fructose-1,6-bisphosphatase (FBPase) is indicated in gray.
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Results
Polysaccharide capsule thickness and growth curves are
specific for glucose, fructose, and sucrose
It has been previously hypothesized that exopolysaccharide
production is reduced in S. pneumoniae in the presence of fructose
as the only carbon source (10). Therefore, we first aimed at deter-
mining the influence of glucose, fructose, and sucrose (disaccha-
ride glucose-fructose) on capsule thickness. Six wildtype (WT)
strains with different serotypes were selected from our collection
(Table 1). The structures of the chosen serotypes have been shown
and can be found in the supporting material (15) (Table S1).
Capsule thickness was determined by FITC-dextran exclu-
sion assay during mid-log phase of growth in a chemically
defined medium (CDM) (Fig. 2). A clear decrease in capsule
production was observed for the six chosen strains grown on
fructose as compared with glucose-fed strains (Fig. 2A). Find-
ings were confirmed in capsule switch mutants with a 106.66
(MLST 2244) background and above mentioned, six serotypes
(Fig. 2B). In addition, serotype 7F WT (208.41) and cps switch
mutant strains (106.66cps208.41) produced the thinnest cap-
sule of all the strains when grown on glucose. We therefore
chose 106.66 (a strain with a thick capsule) and 208.41 (a strain
with a thin capsule) and their mutants for further experiments.
Although capsule thickness was measured at mid-log phase,
Fig. 2C shows that the growth phase in which the bacteria were
harvested did not generally have a large influence on capsule
thickness despite two significant findings.
Inspection of the growth curves revealed that whereas bac-
teria grown on fructose did not reach logarithmic phase any
later than when growing on glucose (Fig. 2, D and E), there was
a reduction in the amount of time before the beginning of autol-
ysis. Sucrose on the other hand had the opposite effect, signifi-
cantly lengthening the time before autolysis in strain 106.66. Both
these effects were reduced in the cps knockout strains (Fig. 2, D
and E), indicating an effect of the presence of capsular polysaccha-
ride on the longevity of the bacteria. The maximum OD600 nm was
significantly different for different serotypes and accordingly, the
point of harvest was adjusted to OD600 nm  0.15 for Serotype 7F
strains and OD600 nm  0.25 for other strains.
Capsule thickness under the influence of glucose, fructose,
and sucrose as the carbon source was also measured by transmis-
sion EM for 106.66 and 208.41 wildtypes as well as their cps switch
mutants (TEM, Fig. 3, A–G) and showed a reduction in exopoly-
saccharide production to almost zero when grown on fructose.
Capsule thickness of strains grown on sucrose as a combination of
the glucose and fructose monosaccharides was also assessed. The
sucrose-fed bacteria were not negatively influenced by the pres-
ence of the fructose moiety and produced thick exopolysaccharide
capsules. In fact, strain 106.66 WT produced larger amounts of
CPS when fed sucrose than when grown on glucose.
RNA-Seq reveals fructose-specific changes that do not occur in
the capsule region
We then performed RNA-Seq of the WT strains 106.66 and
208.41, cps mutants, and their back transformants. The total
number of paired-reads per sample ranged from 4.79 to 39.65
million paired-reads (average: 20 million reads).
In average 99.03% of reads were mapped onto the pneumo-
coccal genome. Between 54.02 and 93.93% of reads (average:
81.47%) mapped to annotated features. Most of these reads
aligned to rRNA. Overall 73.5 or 75.5% of reads aligned to rRNA
or tRNA in strain 106.66 or 208.41, respectively.
The Fig. 4, A and B, show the principal component analysis
(PCA) of all the samples. For the strain 106.66 there is one
outlier for one replicate for the mutant with the 7f capsule from
strain 208.41. The samples clearly separate by media and capsule
for both strains. PCA1 (55–58% of variance) separates data by
“capsule,” PCA2 (18–19% of variance) separates data by medium.
However, the separation by capsule seems to be driven by expres-
sion of genes of capsule region, after removing these genes, there is
no separation by capsule in PCA (data not shown).
Fig. 4, C and D, show the heat maps of the fold-change values
for the top 50 genes for each pairwise comparison of the sam-
ples. We then more closely inspected genes that were part of or
subsequent to the central carbon metabolism of S. pneumoniae.
In both the 106.66 and the 208.41 strains, we observed that
compared to glucose, the glmS and nagA genes (relevant for
peptidoglycan synthesis) are respectively up- and down-regu-
lated in fructose-grown bacteria. The latter was not as signifi-
cant for 208.41 as in 106.66 but similar log-fold values were
received (Tables S2 and S3). RNA-Seq results of glmS and nagA
has been subsequently confirmed with RT-PCR for 106.66 and
208.41 (data not shown). In addition, a number of genes related to
PRPP and subsequent pyrimidine synthesis were also increasingly
expressed in fructose for both strains (carA, carB, pyrB, and pyrR).
Finally and as expected, fructose transporters fructose transporter
genes and Phosphofructokinase (pfk1) were the genes with the
highest log-fold differences. Expression values and full names for
genes of strains after filtering with 106.66 and 208.41 background
can be found as Tables S2 and S3, respectively.
Table 1
S. pneumoniae strains used in this study
ID Serotype Capsule size RFLPa MLSTb
bp
Wildtypes
106.66 6B 17,506 3 2244
203.24 6C 17,677 11 NAc
208.41 7F 24,127 8 191
B109.15 7F 24,127 8 191
201.38 9V 20,856 1 644
207.31 15 18,626 1 199
103.57 23F 22,330 11 507
110.58d nt - 344
cps Janus KO mutants
106.66 cps Januse nt - 3 2244
208.41 cps Januse nt - 8 191
B109.15 cps Januse nt - 8 191
Backtransformants
106.66 cps 106.66e 6B 17,506 3 2244
208.41 cps 208.41e 7F 24,127 8 191
cps switch mutants
208.41 cps 106.66e 6B 17,506 8 191
106.66 cps 203.24e 6C 17,677 3 2,244
106.66 cps 208.41e 7F 24,127 3 2,244
106.66 cps 201.38e 9V 20,856 3 2,244
106.66 cps 207.31e 15 18,626 3 2,244
106.66 cps 103.57e 23F 22,330 3 2,244
a Restriction fragment length polymorphism (RFLP) type according to Ref. 9.
b Multi-locus sequence type (MLST).
c NA, not applicable.
d Whole genome sequencing of nt (non-typeable) strain has been described (52).
e From the collection of strains created by Hathaway et al. (9).
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Analysis of polysaccharide capsule metabolites by 31P NMR
We hypothesized that the lack of capsule polysaccharide in
CDM-fructose was due to fructose not being catabolized to the
capsule precursors such as UDP-glucose or UDP-galactose (Fig.
1). We therefore compared the intracellular metabolite profiles
of S. pneumoniae strains grown in CDM supplemented with
either glucose, fructose, or sucrose. Because phosphorylated
monosaccharide precursors like UDP-glucose and UDP-galac-
tose play a very significant role in capsule biosynthesis (16), we
decided to use 31P NMR to identify and quantify the phosphor-
Figure 2. Capsule thickness from FITC-dextran assay and growth behavior of S. pneumoniae in response to changing carbon source availability. A,
capsule thickness in WT strains; B, capsule thickness of various serotypes on the same genetic background (cps switch mutants); C, capsule thickness measured
during different growth phases, from OD600 nm of 0.1 to 0.3, D, growth behavior of strain 106.66 (serotype 6B) and its cps KO (knock out) mutant, E, growth
behavior of strain 208.41 (serotype 7F) and its cps KO mutant. As for A and B, the experiments were done three times on different days and a total of 15 pictures
(15 values) per strain and carbon source were taken.
Figure 3. Capsule thickness measurements perpendicular to the cell wall from TEM images of cells grown on different carbon sources. Strains 106.66
(A, C, and E) and 208.41 (B, D, and F) grown on glucose (A and B), fructose (C and D) and sucrose (E and F). Results (G) were compiled of between 37 and 67
individual capsule thickness measurements of several individual cells from three separate cultures designated by different symbols.
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ylated metabolites. Fig. 5, A–C, show the relevant regions of a
whole cell extract 31P NMR spectrum of S. pneumoniae, includ-
ing the diphosphodiester region (Fig. 5C). UDP-glucose, UDP-
galactose, UDP-GlcNAc, ATP, PRPP, and fructose 1,6-bispho-
sphate (FBP) were identified by addition of pure compounds to
the samples (spiking). UDP-glucosamine and UDP-N-acetyl-
muramate-pentapeptide were not available or expensive for
spiking and therefore, peaks were assigned by comparison to
spectra from previous studies (11, 16). Other precursor mol-
ecules like TDP-rhamnose and CDP-choline could not be
identified.
The experiments were then conducted for WT strains and
capsule switch mutants (to exclude any effects of the genetic
background) as well as cps (knockout) strains (Fig. 6 and Fig.
S1). We also conducted the experiments using an additional
serotype 7F strain (B109.15) and a naturally nonencapsulated
strain (110.58) (Table 1 and Fig. S2).
Overall, extracts from cps (knockout) strains growing in
media supplemented with glucose or sucrose contained a much
larger amount of UDP-monosaccharide capsule precursors
than their WT counterparts, indicating that the lack of exopo-
lysaccharide biosynthetic mechanism leads to the accumula-
Figure 4. Principal component analysis and heat maps of RNA-seq data. Results are visualized according to the strain background 106.66 (MLST 2244; A)
and 208.41 (MLST 191; B). WT and mutant strains were used (see text and Table 1 for more information). Heat maps show the fold-change values for the top 50
genes for each pairwise comparison of the samples according to the strain background 106.66 (C) and 208.41 (D). Genes that were up- or down-regulated
within both are indicated in bold. Full gene names and expression values of strains with 106.66 and 208.41 background can be found as Tables S2 and S3,
respectively.
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Figure 5. Excerpt from 31P NMR spectra of pneumococcal whole cell ethanol extract (strain 208.41, type 7F). Metabolite peaks for ATP (A) and FBP (B)
have been identified by spiking. Furthermore, PRPP, UDP-Glc, UDP-Gal, and UDP-GlcNAc have been identified by spiking, whereas UDP-MurNAc-p5 and
UDP-GlcN were identified by comparison to previous studies (31) (C).
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tion of the precursors in the cytoplasm (Fig. 6). In addition,
serotype 7F WT isolates accumulated more precursor mole-
cules as compared with 6B strains, which may indicate a less
efficient conversion of precursor metabolites into CPS by the
exopolysaccharide biosynthetic mechanism. This interpreta-
tion is also consistent with the transferability of the effect with
the serotype in a cps switch mutant (106.66cps208.41), indicat-
ing that it is specific to the cps operon (Fig. S1). The resulting
decreased exopolysaccharide production may explain to some
degree the generally thinner capsule of the serotype 7F strains.
Furthermore, cps knockout strains growing in CDM sup-
plemented with fructose as the only carbon source produced
lower amounts of UDP-glucose and UDP-galactose compared
with CDM supplemented with other carbon sources (Fig. 6).
This is also true for the naturally nonencapsulated strain but
absolute values were lower as compared with cps knockout
strains (Fig. S2). FBP production, on the other hand, was
increased in the presence of fructose as compared with glucose.
Another interesting effect was the significant increase of PRPP
production in serotype 6B WT bacteria, which is consistent
with the observed up-regulation of related genes (carA, carB,
pyrB, and pyrR; Fig. 4). In addition, UDP-N-acetylglucosamine
was significantly decreased if grown in fructose in WT and cap-
sule switch strains for serotype 7F but not 6B. The combination
Figure 7. Results of isotopologue profiling. A, excerpts from 1H NMR spectra of serotype 6B capsular polysaccharide showing anomeric proton peaks of
galactose, rhamnose, and glucose (repeat unit structure of serotype 6B is shown in Table S1 and is depicted from Ref. 52). Peak splitting due to the heteronu-
clear coupling between 1H and 13C nuclei is clearly visible in the extract from pneumococci grown on glucose-1-13C. Only minute split peaks are visible in the
extract from bacteria grown on sucrose-(fructose-1-13C) for identical ppm as compared with glucose-1-13C (red dotted lines). B, quantitative representation of
integrals of 13C coupling peaks in % of the total capsule extract from three separate cultures under each condition (repeat measurements for sucrose-13C were
not done due to high pricing of the sugar).
Figure 6. Metabolite levels observed in S. pneumoniae whole cell extracts, biological triplicates from separate cultures. Overall absolute values were
similar to those obtained in a previous study (11). Red, CDM-glucose; blue, CDM-fructose; purple, CDM-sucrose. Differences between conditions were analyzed
by unpaired t test to determine the significance of results. Significance levels are attributed as not significant (ns, p  0.05); *, p  0.05; **, p  0.01; ***, p 
0.001; or ****, p  0.0001.
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of both glucose and fructose monosaccharides in a disaccharide
(sucrose) resulted in a metabolite pattern resembling a mixture
of the two conditions, with the UDP-monosaccharides reach-
ing levels comparable with those reached in CDM-glucose,
whereas FBP levels approached or even exceeded those of the
fructose-fed bacteria.
Utilization of fructose subunit of the disaccharide sucrose
There are several pathways of fructose and sucrose transport
and utilization in bacteria (14) (Fig. 1). Because growth of
S. pneumoniae in CDM-fructose yielded no capsule, but growth
in CDM-sucrose resulted in a thick polysaccharide capsule, we
hypothesized that the fructose subunit of the disaccharide was
mostly metabolized through the glycolysis pathway, allowing
the glucose subunit to be catabolized in capsule production. To
study the metabolic flux of the fructose subunit of sucrose into
the polysaccharide capsule we first cultured the pneumococcal
strain 106.66 (serotype 6B) in media containing carbon 13-la-
beled [13C]glucose-1 or sucrose-([13C]fructose-1) as the only
carbon source. In 1H NMR spectroscopy, protons attached to
13C display a different peak pattern than protons attached to
12C due to the different spin quantum numbers between those
two nuclei (Fig. 7, A and B). Exopolysaccharide from bacteria
fed 13C-labeled glucose showed distinct and complete splitting
of the CPS anomeric proton resonances in 1H NMR spectra and
strongly increased signals at the relevant chemical shifts in 13C
NMR spectra. The changes observed in the NMR spectra are
characteristic of a complete 13C replacement at the relevant
positions in the capsule, confirming the incorporation of the
labeled monosaccharide into the capsule. The proportion of
13C in polysaccharide labeled with [13C]glucose was between
81.7 and 91.2% in all three CPS anomeric proton resonances,
indicating a very efficient labeling (Fig. 7B). Subsequently, we
performed an experiment with the labeled fructose moiety of
sucrose-([13C]fructose-1) and only observed small 13C satellite
resonances, indicating that its use in capsule biosynthesis is not
very efficient (Fig. 7A). More specifically, the proportion of 13C
in polysaccharide labeled on [13C]sucrose only contained 4.5%
13C for the galactose resonance at 5.53 ppm, 4.7% for the rham-
nose resonance at 5.07 ppm, and 6.2% for the glucose resonance
at 5.05 ppm (Fig. 7B). This finding supports our hypothesis that
the polysaccharide capsule is biosynthesized from mostly the
glucose subunit of sucrose, whereas the fructose subunit is
mostly metabolized through the glycolysis pathway.
Discussion
The polysaccharide capsule is a major virulence factor and
surrounds most clinical strains of the Gram-positive human
pathogen S. pneumoniae. It functions as a shield protecting
underlying bacterial structures from recognition by the
immune system, interfering with complement deposition,
phagocytosis, and mucus-mediated clearance (17–22). S. pneu-
moniae regulates the thickness of the polysaccharide capsule in
response to its environment and this is key in colonization and
invasion of epithelial host cells (23). However, despite the
importance of the capsule, the mechanisms and environmental
conditions that influence capsular polysaccharide expression
are not yet very well-understood (23). It has been previously
hypothesized that CPS production in S. pneumoniae is reduced
when grown on fructose as compared with glucose as the car-
bon source but the mechanism was unclear (10). Within this
study, we confirmed that this phenomenon is indeed true for a
large number of pneumococcal strains and assessed the mech-
anism for this phenotypic phenomenon by measuring the intra-
cellular phosphorylated metabolites. In addition, we describe
the relevant transcriptional changes from RNA-Seq data if
S. pneumoniae is grown in fructose as compared with glucose.
Finally, we reveal that labeled glucose rather than fructose is
incorporated into the capsule if grown in sucrose by stable iso-
tope tracing. Understanding the expression of the capsule in
response to the environment is important to future vaccine
design.
Pneumococcimetabolizecarbohydratessuchasthemonosac-
charides fructose, mannose, glucose, galactose, GlcNAc, disac-
charides such as sucrose, lactose, and cellobiose, or trisaccha-
rides such as raffinose, which all enter the glycolytic pathway
(12). In addition, carbohydrates are involved in the biosynthetic
pathways of housekeeping and nonhousekeeping (CPS-spe-
cific) components of S. pneumoniae CPS (24). Phosphorylated
metabolites such as UDP-glucose and UDP-galactose are espe-
cially important as precursor molecules for capsule production
(11). We therefore focused on quantifying phosphorylated
metabolites by 31P NMR within this study. This method has
been used previously to investigate the effect of ccpA deletion
on intracellular concentrations of phosphorylated metabolites
during growth on glucose or galactose (11). To our knowledge,
it has not yet been used to study capsule biosynthesis within
S. pneumoniae. As compared with HPLC-MS and GC-MS
methods for characterizing the pneumococcal metabolome
(25), 31P NMR only reveals a small subset of (phosphorylated)
metabolites. However, 31P NMR can distinguish metabolites
with identical mass (like the important capsule precursor UDP-
glucose versus UDP-galactose), which may not be as straight-
forward with HPLC-MS and GC-MS methods.
By quantifying phosphorylated metabolites, we show that the
intracellular concentrations of UDP-glucose and UDP-galac-
tose are drastically decreased in cps pneumococcal strains if
grown in fructose compared with glucose. This reveals that the
pneumococcus is not able to produce the relevant precursors
for the biosynthesis of the pneumococcal capsule under fruc-
tose conditions. In contrast, exopolysaccharide (EPS) produc-
tion in Bifidobacterium longum has been shown to remain sim-
ilar when grown on fructose, galactose, and glucose (26). In
accordance with our findings, the concentrations of the same
two EPS precursors, UDP-glucose and UDP-galactose, were
significantly lower in a Lactococcus lactis strain containing the
EPS gene cluster (Eps) than in the nonproducer strain
MG5267 (Eps) (16). In a further study focusing on L. lactis
subsp. cremoris, it has been shown that fructose is taken up
mainly via the fructose PTS resulting in fructose 1-phosphate
(27). In addition, combined actions of 1-phosphofructokinase
and FBPase would be required to form essential biomass pre-
cursors (27). We hypothesize that the same is true for S. pneu-
moniae due to the following two reasons. First, we revealed that
the relevant PTS transporter and pfk1 are highly up-regulated
in fructose from our RNA-Seq data. Considering earlier find-
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ings suggesting the presence of fruA is essential for growth on
fructose (12), we assume that fructose is indeed primarily
imported by this PTS transporter. Second, due to the absence of
UDP-glucose and UDP-galactose if grown in fructose, FBPase
activity seems to be nearly absent in S. pneumoniae. However,
the product of FBPase, fructose 6-phosphate is essential for
polysaccharide capsule production but also peptidoglycan syn-
thesis. Two additional routes for the utilization of fructose have
been suggested for E. coli (14). Although much less predomi-
nant, the additional routes facilitate the production of fructose
6-phosphate. We do not know if they are also the two additional
routes for fructose utilization within S. pneumoniae at this
point. However, we noted an up- and down-regulation of glmS
and nagB/nagA, respectively. These genes are essential for the
production of UDP-GlcNAc to build the cell wall, which has
been described to be tightly regulated (28, 29). More specifi-
cally, glmS RNA-specific degradation through the possible par-
ticipation of a glmS riboswitch mechanism has been described
(28, 29). Based on our expression results, such degradation
might be more abundant if grown on glucose than on fructose,
but more detailed experiments will be necessary.
Recently, a mechanism of regulation of the pyr operon by the
pyrR RNA element has been proposed for S. pneumoniae (30).
It has been shown that in the presence of high UMP but low
PRPP, PyrR binds to the pyrR RNA and results in the formation
of a premature terminator, disrupting the anti-terminator
formed when UMP is low (and PRPP high), resulting in tran-
scription termination (30). Within our study, we found both
increased intercellular PRPP and expression of genes of the pyr
operon if grown on fructose. This therefore suggests a tight
regulation of this operon as suggested by Warrier et al. (30).
Having analyzed the mechanism of CPS biosynthesis and
nonbiosynthesis of S. pneumoniae grown on glucose and fruc-
tose, respectively, we then were wondering how the disaccha-
ride sucrose (fructose-glucose) would be incorporated into the
capsule. Sucrose is an important dietary glycan (4) and sucrose
metabolism contributes to in vivo fitness of S. pneumoniae (31).
Sucrose is probably imported mainly via a PTS transporters
(ScrT) and subsequently degraded/hydrolyzed (by ScrH) to glu-
cose 6-phosphate and fructose (4). It is hypothesized that a
putative fructokinase (scrK) produces fructose 6-phosphate
(31), which, like glucose 6-phosphate, could be used as sub-
strate for the production of CPS precursor molecules, such as
UDP-glucose and UDP-galactose, and, subsequently, capsule
biosynthesis (Fig. 1). However, in contrast to labeled glucose,
we only noted an incorporation of less than 10% of labeled fruc-
tose into the capsule of our serotype 6B strain. More specifi-
cally, we received a very reduced labeling of the anomeric pro-
tons of rhamnose, galactose, and glucose, which have been
previously shown to be characteristic of serotype 6B isolates in
NMR spectra (32). Our results are therefore able to quantify the
proportion of metabolites used for CPS production within the
central carbon metabolism if glucose and fructose monosaccha-
rides are present in equal concentrations within S. pneumoniae
(as derived from the disaccharide sucrose). We did not consis-
tently detect a decreased production in UDP-N-acetylmura-
mate-pentapeptide in non-EPS producing strains as reported
previously (16).
A major strength of our study is the implementation and
usage of 31P NMR for quantifying phosphorylated (including
capsule precursor) metabolites. Doing this for strains grown on
glucose as compared with fructose, we were able to provide
mechanistic evidence for the absence of the capsule in the latter
condition. By additionally performing RNA-Seq, we were also
able to reveal relevant gene expression differences. Another
particular strength of our study is the usage of isotopologue
profiling, which offers the possibility to decipher the incorpo-
ration of the distinct carbon sources into the capsule. This may
seem less important for monosaccharides such as glucose (as
incorporation of 13C-labeled glucose is nearly 100%) but, in
contrast, is very relevant for di- and oligosaccharides (such as
sucrose),astheproportionofutilizationofthedifferentmonosac-
charides in CPS biosynthesis is unknown.
A limitation of the study is the fact that we did not yet check
the influence of larger fructooligosaccharides (FOS) on the
expression of the capsule. FOS are taken up by different (ABC)
transporters (4, 33) and, once imported, are thought to be
degraded by FusH (4). The exact products of this enzymatic
reaction and their effects on CPS biosynthesis are unknown.
Also, we did not investigate the effects of other monosaccha-
rides, such as galactose, mannose, and GlcNAc on CPS produc-
tion, as our main aim in this study was to elucidate the cause of
the absence of CPS in strains grown on fructose. It is known that
pneumococcal strains without capsule are more prone to
opsonophagocytosis and, therefore, it remains to be analyzed if
increased concentrations of fructose and/or FOS could poten-
tially be used as prebiotic for preventing pneumococcal coloni-
zation and/or subsequent invasive disease.
We did not detect UDP-GalNac in the 31P spectra of the
strains with 7F serotype, which was also not reported for pneu-
mococcal strain D39 in a recent study (11). This is perhaps
surprising considering that the serotype 7F strains possess Gal-
Nac within the capsule structure (Table S1) but the building of
UDP-GalNac is probably important for all pneumococcal
strains for the biosynthesis of teichoic acids (34). We may only
speculate if UDP-GalNAc is generally consumed very rapidly in
S. pneumoniae and therefore difficult to detect using the meth-
ods presented.
However, we observed a less efficient conversion of precur-
sor metabolites into the CPS in 7F. The accumulation of UDP-
precursors could be the result of a relative bottle-neck step in
epimerization done by the GalE enzyme (Fig. 1), which has been
shown to be able to epimerize both, UDP-glucose/UDP-galac-
tose, and UDP-GlcNAc-UDP-Gal-NAc in S. pneumoniae (35).
In summary, this study reveals and quantifies the dual utili-
zation of carbohydrates for capsule production and glycolysis.
It further shows that some serotypes (e.g. 6B) are more efficient
in the conversion of precursor molecules to capsular polysac-
charide than others (e.g. 7F). Understanding the metabolic flux
of different carbohydrates and their relationship to capsule
expression is important considering the wide range of host-
derived glycans the pneumococcus encounters during its inter-
action in the human host (4, 7). Knowledge about the pneumo-
coccal metabolism and mechanism of capsule biosynthesis is
also important to recognize potential new drug targets.
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Experimental procedures
Bacterial strains and growth conditions
The bacterial strains for this study were selected from the
collection of the Swiss National Reference Centre for Pneumo-
cocci. Strains for the preliminary experiments were chosen to
include a variety of serotypes. This included strains of serotypes
6B, 6C, 7F, 9V, 15, and 23F and their capsule switch mutants.
The structures of the serotypes have been shown and can be
found in the supporting material (15) (Table S1). For the more
detailed analyses, strains 106.66 (serotype 6B) and 208.41 (sero-
type 7F) were chosen as examples of serotypes more commonly
associated with commensal colonization of the nasopharynx
and invasive disease, respectively, as well as representing one
strain with a thick polysaccharide capsule and one with a thin
capsule (Table 1). Bacteria were cultured as described previ-
ously (36). Briefly, bacteria were streaked out on CSBA plates
and grown for 10 h at 37 °C in a 5% CO2 atmosphere. They
were then inoculated into tubes containing modified Lacks
medium (37–39) supplemented with glucose and grown to an
OD600 nm of 0.5. After centrifugation and washing, 3 ml of bac-
terial suspension at OD600 nm 0.5 were added to 150 ml of CDM
supplemented with a single carbon source at a concentration of
5.5 mM (5.5 mM glucose is approximately naturally found in the
blood). For the isotopologue profiling experiments, CDM con-
taining 5.5 mM of either 100% labeled or unlabeled carbohy-
drates were used. The cultures were then grown further to mid-
logarithmic phase. Bacterial growth was tracked by measuring
the optical density at a wavelength of 600 nm (OD600 nm) using
a Thermo Scientific Helios Epsilon UV-visible spectrophotom-
eter with an adapter to allow measurement of OD600 nm directly
in the culture tubes.
FITC dextran capsule thickness measurements
Capsule thickness was evaluated in biological triplicate by
fluorescence microscopy according to a method previously
described (10, 40, 41). Briefly, cells were harvested by centrifu-
gation at mid-log phase, washed, and resuspended. Cells were
prepared for visualization on a microscope slide and imaged as
described before (9). At least 5 brightfield and fluorescence
images per sample were recorded and the area of fluorescence
occlusion per cell was calculated using free ImageJ software as
previously described (40). The experiments were done three
times on different days and a total of 15 pictures (15 values)
per strains and carbon source were taken.
TEM imaging
Cells were grown using the methods described above and
harvested at mid-log phase. Samples for TEM imaging were
prepared as described before (40, 42). In brief, bacteria were
pelleted by centrifugation (5000 rpm for 5 min) and the super-
natant was discarded. Bacteria were then cryopreserved by
high-pressure freezing (HPF) as described by Studer et al. (42)
using 1.4  0.1-mm membrane carriers (Leica Microsystems,
Vienna) coated with L--phosphatidylcholine (Fluka, Buchs,
Switzerland). Acetone containing 2% osmium tetroxide, 0.1%
uranyl acetate, 0.2% ruthenium hexamine trichloride and a
total of 4% H2O served as the medium for freeze substitution.
The ruthenium hexamine trichloride was added to improve
capsule resolution (43). After substitution, bacteria were
washed in acetone (Merck, Darmstadt, Germany) four times for
30 min each, they were then incubated for 2 h and 30 min in
acetone:Epon (2:1) and 4 h in acetone:Epon (1:1) followed by an
overnight incubation with acetone:Epon (1:2) at room temper-
ature. The next day, samples were embedded in Epon (Sigma)
and left to harden at 60 °C for 5 days. Ultrathin sections (75 nm)
were produced with an ultramicrotome UC6 (Leica Microsys-
tems, Vienna, Austria). The sections, mounted on Formvar
(Ted Pella Inc. USA)-coated single slot copper grids, were
stained with uranyl acetate (Electron Microscopy Sciences,
Hatfield, PA) and lead citrate (Leica Microsystems, Vienna,
Austria) with an ultrostainer (Leica Microsystems). Sections
were examined with a transmission electron microscope
(CM12, Philips, Eindhoven) equipped with a digital camera
(Morada, Soft Imaging System, Münster, Germany) and image
analysis software (iTEM). Measurements of capsule thickness
were conducted on several images and several points on cell
bodies perpendicular to the pneumococcal cell wall using the
software ImageJ. For each strain and carbon source, a total of
between 37 and 67 measurements were conducted.
Whole genome and RNA-Seq of WT and mutant strains
We first sequenced the reference genomes (106.66 and
208.41) by Illumina HiSeq 2000 (Illumina Inc.). The resulting
reads were de novo assembled using SPAdes (44). Gene predic-
tion was performed with Prodigal (45) and annotation was a
carry-over from strain 23F. The assembled genomes are avail-
able under PRJNA554545.
Overall for each strain 7 samples each in 3 replicates were
analyzed with RNA-sequencing with the accession number
PRJNA554543. The 7 samples were the original strain, a mutant
with transformed capsule from the other stain and a mutant
with the back transformed capsule in two media; with fructose
or glucose; and a mutant without a capsule in medium with
glucose. RNA libraries were sequenced as paired-end reads on
Illumina. Reads from RNA-sequencing were mapped to the ref-
erence genomes with bowtie2 (46, 47) and following counting
of the reads was performed with featureCounts (48).
Genes annotated as rRNA, tRNA, transposases, and manu-
ally confirmed hypothetical proteins were excluded from the
analysis. After this step 2095 and 1944 genes from 2163 and
1997 genes were left for strains 106.66 and 208.41, respectively.
Reads were then normalized as a regularized log (rlog), a data
transformation method in DESeq2 (49), and as transcripts per
million (TPM) (50). Low expression genes were categorized
from TPM values. Decile values were used to partition expres-
sion values of genes into 10 classes. The first decile was used as
the maximum limit for low expressed genes. 2.1 TPM for strain
106.66 and 2.9 TPM for strain 208.41 were set as the minimum
expression value, 1966 for strain 106.66 and 1829 genes for
strain 208.41 were left for further analysis. The very short genes
were also removed from the analysis. The same parameters as
for low expressed genes were used: the first decile was used to
define the short genes. With these criteria all genes shorter than
225 bases (strain 106.66) or 240 bases (strain 208.41) were
removed from further analysis. Overall 145 genes in strain
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106.66 and 148 genes in strain 208.41 were removed. After all
filtering 86% of genes were left for the analysis (1821 of2163
genes for strain 106.66, and 1681 of1997 genes for strain 208.41)
(Tables S2 and S3).
Fold-changes were calculated for each pair of conditions,
resulting in a total of 21 comparisons. Fold-changes of genes for
which significance could not be calculated confidently, defined
as adjusted p value greater than 0.01, were set to 0. Then the
fold-changes were calculated over all conditions comparing the
values in glucose and fructose media. The fold-changes of genes
with an adjusted p value bigger than 0.01 were set to 0. The
ranking was made based on this comparison. For the ranking,
the absolute value of the fold-change was taken. The capsule
genes were analyzed separately. The fold-changes of genes for
which none of the pairwise comparisons was significant were
also set to 0. Overall 737 genes for strain 106.66 and 756 genes
for strain 208.41 had significant fold-changes and 41 genes for
strain 106.66 and 47 genes for strain 208.41 had fold-changes
bigger than 2. The top 50 genes with the highest absolute fold-
change were used for further analysis.
Intracellular metabolite extraction
Whole cell EtOH extracts were prepared using a slight mod-
ification of the method of Ramos et al. (16). In brief, the bacteria
cultured in chemically defined medium were harvested by cen-
trifugation and washed once each with ice-cold 0.8% NaCl and
ice-cold H2O. They were then resuspended in ice-cold H2O and
diluted with absolute EtOH at 20 °C to a concentration of 60%
EtOH. Cells were disrupted via vigorous shaking for 2 h at 0 °C.
Cell debris was removed by ultracentrifugation and ultrafiltra-
tion (Amicon 10-kDa centrifuge filter) and the solvent was
evaporated under reduced pressure. Dried samples were
weighed and dissolved in 100 l of NMR buffer (20 mM MOPS,
5 mM NaOAc, and 1 mM EDTA in D2O with 0.1% phosphono-
acetic acid (PPA), and 0.1% TSP, pH 7.4) transferred into
1.7-mm NMR microtubes and submitted for measurement of
31P NMR spectra.
Capsular polysaccharide extraction and analysis
Extracts of the capsular polysaccharide were obtained as
described previously (9, 36). For isotopologue profiling experi-
ments, the pneumococci were provided a single carbon source,
either unlabeled or labeled with 13C in the 1-position at 100%
concentration (5.5 mM). For serotype analysis, regular unla-
beled saccharides were used. Bacterial cultures were grown as
described above, harvested by centrifugation, and washed with
ice-cold H2O. After resuspension, capsule polysaccharide was
separated from the cells by addition of buffer-saturated phenol
to a concentration of 1% and incubation overnight at room
temperature. Cell debris was removed by centrifugation and
nucleotides and peptides were digested by addition of nuclease
and proteinase K, respectively. CPS was separated from smaller
molecules using Millipore Amicon Ultra 30-kDa cut off mem-
brane centrifugal filter units and the solvent was removed
under reduced pressure. Dried capsule polysaccharide samples
were dissolved in 100 l of D2O transferred into 1.7-mm NMR
microtubes and submitted for NMR measurements.
Metabolic flux analysis by isotopologue profiling
Metabolic flux analysis of carbohydrate uptake was based
on the principle of 13C-based isotopologue profiling (51).
Bacteria were grown as described above using 13C-labeled
monosaccharides as the carbon source. In particular,
[13C]glucose-1 was used to create completely labeled capsu-
lar polysaccharides as a reference point. To track the meta-
bolic flux of different monosaccharides, sucrose with an
unlabeled glucose subunit and a labeled fructose 1-13C sub-
unit was used. By extracting the capsule and analyzing it by
NMR as described, it was possible to determine the propor-
tions of labeled and unlabeled saccharides in the polysaccha-
ride capsule.
NMR measurements
NMR data were collected on a Bruker Avance II (500 MHz;
1H) spectrometer equipped with a 1.7-mm triple-resonance
(1H, 13C, 31P) microprobe head. The samples were prepared as
follows. The full amount of each capsule extract (5–10 mg)
was dissolved in 100 l of NMR buffer (MOPS/EDTA in D2O
with 0.1% PPA and 0.1% TSP, pH 7.4) or pure D2O and 65 l of
the resulting mixtures were transferred into 1.7-mm NMR
tubes. 31P spectra were acquired using 4096 scans with a
spectral width of 40760.9 Hz, a recycling delay of 2 s, and an
acquisition time of 0.402 s. 1H spectra were recorded using
1024 scans with a spectral width of 12500.0 Hz, a recycling
delay of 1 s, and an acquisition time of 1.311 s. All spectra
were acquired at a regulated temperature of 298 K. All exper-
iments were recorded using the TopSpin software, version
3.2 (Bruker Biospin), and processed using TopSpin version
4.0.5. For the intracellular metabolite extracts, one-dimen-
sional 31P NMR was used, whereas for the capsule extracts,
one-dimensional 1H NMR as well as two-dimensional
1H/13C-heteronuclear single quantum coherence spectra
were recorded.
Identification and quantification of metabolite signals
31P NMR resonances were assigned to metabolites by spiking
samples with specific metabolites in known concentrations and
comparison to previous studies. Quantification of the metabolites
was achieved by comparison to the quantity of the internal PPA
standard following a classical calibration procedure. A specific
conversion factor was obtained from this calibration for each
metabolite and was used to calculate absolute amounts from the
NMR integrals of the metabolites and PPA. To ensure consistency
of the results, all metabolite extract samples were dissolved in
NMR buffer from the same batch. Metabolite concentration data
were analyzed by unpaired t test to determine the significance of
results.
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